SAGE Therapeutics
Develops and delivers novel medicines for most debilitating and disabling central nervous system disorders. Learn more
Launch date
Employees
Market cap
€435m
Enterprise valuation
(€152m) (Public information from Sep 2024)
Share price
$7.9 SAGE
Raleigh North Carolina (HQ)
Authorizing premium user...